116 results on '"Falo C"'
Search Results
2. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
3. 169P A real-world molecular pre-screening program in advanced breast cancer (ABC) at Institut Català d'Oncologia l'Hospitalet: Clinical practice study to assess treatment-decision choice based on molecular results
4. 218P Characteristics and outcomes of HER2-low (H-Low) and HER2-zero (H-0) advanced breast cancer (ABC) patients (pts) from GEICAM/2014-03 (RegistEM) registry
5. 11P Independent validation of the HER2DX assay in HER2-positive (HER2+) breast cancer (BC) treated with neoadjuvant paclitaxel, trastuzumab and pertuzumab (THP): A correlative analysis from the BiOnHER study
6. Axillary Nodal Management in the setting of Neoadjuvant Chemotherapy
7. Predictive factors of macrometastasis in sentinel lymph node in invasive lobular carcinoma
8. Risk factors for lymphedema after breast surgery: A prospective cohort study in the era of sentinel lymph node biopsy
9. Risk Factors for Lymphedema After Breast Surgery: a Prospective Cohort Study in the Era of Sentinel Lymph Node Biopsy
10. 14P Immunomodulatory effect of denosumab in early breast cancer: Preliminary results of a randomized window-opportunity clinical trial D-Biomark
11. Mutational profile from circulating tumor DNA in triple negative breast cancer: Results from the prospective registry of unresectable locally advanced or metastatic breast cancer GEICAM/2014-03 (RegistEM)
12. Geicam/2014-03 (RegisTEM): A prospective registry of unresectable locally advanced or metastatic breast cancer: Characteristics of a subset of patients with triple negative subtype
13. Characteristics of HR+/HER2-patients with recurrent disease from a prospective registry of unresectable locally advanced or metastatic breast cancer: GEICAM/2014-03 (RegistEM)
14. 289P Results of the window-of-opportunity clinical trial D-BIOMARK: Study of biomarkers of the antitumor activity of denosumab and its role as a modulator of the immune response in early breast cancer
15. 149P Assessing the effect of single dose trastuzumab and pertuzumab (HP) on biological changes and pathological complete response (pCR) in ERBB2+ Breast Cancer: Results from the neoadjuvant BionHER study
16. Risk factors for lymphedema after breast surgery: A prospective cohort study in the era of sentinel lymph node biopsy.
17. 203 (PB-116) Poster - Axillary Nodal Management in the setting of Neoadjuvant Chemotherapy
18. 56 (PB-056) Poster - Predictive factors of macrometastasis in sentinel lymph node in invasive lobular carcinoma
19. Influence of age on the indication of adjuvant chemotherapy in early breast cancer using Oncotype DX. An analysis of 240 patients treated in the Institut Catala d’Oncologia (ICO) hospitals
20. Residual cancer burden as a prognostic factor in a large series of neoadjuvant chemotherapy. Subgroup analysis per molecular surrogated subtypes
21. Abstract P5-15-09: Impact of oncotype dx genetic signature used in early breast cancer. Clinical and economic analisys of a 110 patient cohort treated in the Catalan Oncologic Institute (ICO), Spain
22. Abstract P3-13-07: Is radiofrequency ablation better than lumpectomy for margin status in breast cancer? Results of a randomized clinical trial
23. Abstract P2-08-58: Prognostic factors of survival in node positive breast cancer patients after neoadjuvant chemotherapy in a large series after 5y follow-up: Can response overcome the poor prognosis of nodal stage?
24. ‘Real world data’ of genomic sequencing for personalised therapy
25. Predictive factors for considering to avoid axilar lymphadenectomy in selected node positive breast cancer patients after neoadjuvant chemotherapy
26. Evaluation of tumor-infiltrating lymphocites (TIL) and response to neoadjuvant chemotherapy according to RCB index in a series of 157 breast cancer cases
27. Abstract P2-09-11: PAM50 intrinsic subtyping as a predictor of pathological complete response to neoadjuvant trastuzumab-based chemotherapy in early HER2-positive breast cancer
28. Abstract P5-21-23: Evaluation of the drug interaction potential of palbociclib and exemestane – Results from the PEARL pharmacokinetic sub-Study
29. Abstract P4-08-08: Biomarkers to predict distant recurrence free survival after neoadjuvant endocrine therapy in breast cancer. A long follow up retrospective study
30. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
31. CDC group IV c-2 infection in a stem cell transplant recipient
32. Abstract P4-21-32: Treatment of early HER2-positive breast cancer in trastuzumab era in everyday clinical practice: An overview after 10 years of its approval
33. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
34. 241P - Residual cancer burden as a prognostic factor in a large series of neoadjuvant chemotherapy. Subgroup analysis per molecular surrogated subtypes
35. 209P - Influence of age on the indication of adjuvant chemotherapy in early breast cancer using Oncotype DX. An analysis of 240 patients treated in the Institut Catala d’Oncologia (ICO) hospitals
36. Breast-GPA and type of treatment predictors of survival in brain metastasis patients
37. Abstract P2-08-31: Tumor and axillar downstaging as a prognostic factor and evaluation of effectiveness to primary chemotherapy in breast cancer: A retrospective analysis
38. Abstract P6-11-04: Use of Mammaprint© (MMP) genetic signature in early breast cancer patients. Economic analisys of a 129 patient cohort treated in three Spanish hospitals
39. 474 (PB-107) - Evaluation of tumor-infiltrating lymphocites (TIL) and response to neoadjuvant chemotherapy according to RCB index in a series of 157 breast cancer cases
40. 188 (PB-089) - Predictive factors for considering to avoid axilar lymphadenectomy in selected node positive breast cancer patients after neoadjuvant chemotherapy
41. P085 Target axillary disecction in cN2 breast cancer patients after neoadjuvant chemotherapy. Preliminary results.
42. Networks of Hospitals in three health regions of Catalonia, Spain
43. 257P - Breast-GPA and type of treatment predictors of survival in brain metastasis patients
44. Abstract P1-01-26: Clinical Implications of pN0 mol+ in Breast Cancer Patients
45. 399 Pathological changes after primary chemotherapy in breast operable carcinoma. Correlation with survival after 14 years of follow-up
46. Correlation between pN0(mol+) and standard clinico-pathological prognostic factors in SLN of breast cancer patients.
47. Nesting biology and social structure of Euglossa (Euglossa) townsendi Cockerell (Hymenoptera, Apidae, Euglossini)
48. Nesting biology and nest re-use ofEulaema nigrita (Hymenoptera: Apidae, Euglossini)
49. Nest re-use and communal nesting inMicrothurge corumbae (Hymenoptera, Megachilidae), with special reference to nest defense
50. In vitro Interaction of Heterologous Platelets with Isolated Neoplastic Cells from a Murine Mammary Gland Tumor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.